BioVenture

RootPath Genomics, Inc. is a biotechnology company founded in 2017 and headquartered in Cambridge, Massachusetts. The company specializes in developing a next-generation T-cell therapy platform that integrates precision medicine with cancer immunotherapy. By focusing on the analysis and manipulation of individual immune cells, RootPath aims to enhance immune responses and improve cell therapy efficacy. Its innovative technologies allow for precise monitoring and modulation of the immune system, which is intended to revolutionize the diagnosis and treatment of cancer.

Shanhai Innovation is a biological development company focused on supramolecular science and technology research and development. It provides supramolecular material, organic liquid, ionic salt, and biocatalysis. It serves biomedicine, daily cosmetics, health food, medical equipment, and food additives.

Hengyu Medical is a medical device firm focused on R&D and production of IVUS and optical coherence tomography, and catheter equipment.

Degron Therapeutics is a drug discovery company focused on developing a new class of therapeutics centered around targeted protein degradation. The company specializes in molecular glue degrader drugs, which are small molecules designed to selectively target and degrade specific proteins associated with various diseases. Degron Therapeutics aims to lead the field of small molecule molecular glue degrader medicines by leveraging its expertise to identify and validate challenging disease targets that traditional small molecule inhibitors cannot effectively address. The company is committed to addressing unmet medical needs across a broad range of therapeutic areas by developing innovative protein degradation drugs, utilizing its advanced molecular glue platform technology to enhance treatment efficacy.

MyoGene Life Sciences is a regenerative medical company that specializes in the promotion of its regenerative repair material product line for bone repair.

AusperBio is a clinical-stage biopharmaceutical company focused on developing innovative treatments for hepatitis B and advancing oligonucleotide therapeutics. Utilizing its proprietary Med-Oligo™ ASO platform, AusperBio aims to deliver effective targeted therapies that leverage antisense oligonucleotide technology. The company is dedicated to transforming the treatment landscape for hepatitis B, with an emphasis on finding a cure and providing protection through novel therapeutic approaches. Additionally, AusperBio's research extends to addressing a variety of diseases, including viral infections, metabolic conditions, genetic disorders, and immune diseases, thereby broadening the potential impact of its therapeutic innovations.

Yili Pharmaceutical is a pharmaceutical R&D company that mainly engages in biochemical product technology R&D, medical research and experimental development, engineering and technology research and experimental development, and software development.

Allink Biotherapeutics is a biopharmaceutical company that focuses on oncology and immunological treatment.

Macrolux Medical is a medical technology company that specializes in endoscopic interventional solutions. It focuses on developing devices for both diagnosis and treatment across various medical fields, including urology, respiratory, and digestive health. By promoting these innovative solutions to a wide range of medical customers, Macrolux aims to enhance patient outcomes through earlier detection and improved treatment options. The company's commitment to advancing endoscopic therapy positions it as a key player in the medical device sector.

Youzhong New Materials is a micro-nano device R&D company that designs, develops, and manufactures micro-nano devices using nanoimprint core technology.

Secretech is a research and development-driven biotechnology company focused on creating biomarkers and cellular exosomes. It specializes in developing a molecular detection technology platform designed to offer innovative solutions across scientific, clinical, and drug discovery sectors. The company is dedicated to advancing a new generation of molecular detection methods, integrated with advanced computational biology algorithms. This approach enables Secretech to deliver robust proteomics analysis tools that facilitate the rapid discovery of new molecular markers.

Chuanxin Biotech is an RNA drug research and development service provider.

Changsha Morning Shine is an innovative pharmaceutical company that specializes in R&D outsourcing, biomedicine, chemical drugs, and biotechnology services.

Shenzhen CardioACC Ltd specializes in advanced cardiovascular interventional, natural cavity imaging and advanced diagnostic procedures.

KeChow Pharma, established in 2014 and headquartered in Shanghai, China, is a biopharmaceutical company specializing in novel drug discovery. It concentrates on developing targeted small molecule drugs as alternatives to existing therapies, collaborating with partners for co-development.

Gachun Biotech is a pharmaceutical intermediates industrialization platform that focuses on APIs, or pharmaceutical intermediates.

Huili Pharmaceutical is a drug delivery platform that specializes in the development of nanoparticles and microsphere preparation equipment.

Synapsor is a medical-grade wearable device research and development company, oriented to the AI+ medical and health field, and is committed to the development and manufacturing of AI-powered medical-grade smart wearable devices, including AI-ECG artificial intelligence. Diagnostic analysis system, CUMS uric acid blood glucose and cholesterol monitoring system, etc. The company has recently received tens of millions of yuan in Series B investment, and the investor is Xiaomi Technology.

Essentia Biosciences is a biotechnology company that specializes in the development of cells, gene technology drugs, and medical devices.

Gene Cradle is a genetic company that develops gene therapy drugs to treat rare genetic diseases as well as chronic diseases.

Jiamuyao Medical specialized in developing an energy platform for the comprehensive treatment of complex intravascular lesions.

Xiguang Bio focuses on the production of diagnostic reagents and provides chemiluminescent raw materials and overall system technology solutions.

Beyond Therapeutics employs its ExCEED technology to speed the discovery and development of novel medications for unmet therapeutic needs.

Suzhou Panomic Biomedical Technology Co., Ltd. (BioNovoGene) was founded in Suzhou Industrial Park Bio-Nano Park in 2013. It is a leading high-tech enterprise focusing on metabolomics in China. Since its establishment, it has established a complete metabolomics detection and analysis platform - PanomicTM / Bionovogene, including metabolite preprocessing platform, high-resolution mass spectrometry analysis platform, and metabolomics data analysis with independent intellectual property rights The system has perfect biomarker discovery capabilities and clinical application capabilities. The company's scientific research team has a rich background, covering biochemistry, bioinformatics, epidemiology and biostatistics, computer science, etc., and has a consultant team composed of top scientists and clinicians.

Chromai is a company specializing in high-performance intelligent liquid chromatography and medical diagnostic solutions. It focuses on independent innovation and aims to contribute to the revitalization of the national industry. Chromai develops advanced medical molecular diagnostics and testing technologies that streamline the diagnostic process. By leveraging a combination of artificial intelligence, Big Data, and Internet of Things (IoT) technologies alongside leading analysis and detection methods, the company is dedicated to enhancing the fields of health in vitro diagnostics (IVD), environmental protection, and scientific instruments. This commitment enables medical users to achieve simplified and efficient diagnostic and testing analyses.

XellSmart is a company based in Minhang District, Shanghai, China, focused on developing stem cell treatment solutions for various degenerative diseases that currently lack effective clinical treatments. The firm aims to enhance disease treatment and facilitate drug discovery through innovative stem cell therapies. XellSmart is dedicated to offering large-scale and cost-effective stem cell treatment, replacement, and transplantation options, specifically targeting major conditions like Parkinson's disease. By advancing these solutions, XellSmart seeks to provide patients with viable clinical alternatives to improve their health outcomes.

Ruoyi Biotech is a developer of macromolecular drug delivery technology.

Innovision is a company that specializes in developing auxiliary diagnosis and treatment systems tailored for endoscopy centers in hospitals. By leveraging artificial intelligence deep learning technology, Innovision processes digestive endoscopy image data to assist in medical imaging-assisted diagnosis of the digestive system. This innovative approach helps hospitals enhance work efficiency and alleviate the workload on endoscopy doctors, ultimately reducing the need for redundant labor.

Chime Biologics Limited is a Contract Development and Manufacturing Organization (CDMO) based in Wuhan, China, specializing in biopharmaceutical development and manufacturing services. Established in 2013, the company offers a wide range of services, including drug substance and drug product manufacturing, cell line development, and protein science characterization. It also supports clients with technical transfer, regulatory guidance, and project management to ensure a comprehensive solution throughout the biopharmaceutical development lifecycle. Chime Biologics focuses on delivering customer-centric, cost-effective, high-quality services that cater to the evolving needs of the biopharmaceutical industry, facilitating early-stage development through late-stage clinical research and commercial production.

Power Site is a modern technology enterprise that supplies X-ray imaging core components. It mainly provides high-voltage generators (HVG), combined X-ray sources, power distribution units (PDU), and other core components overall solutions for X-ray imaging systems. The products are mainly used in high-end X-ray imaging systems such as CT, DR, mammography, C-arm, CBCT, security inspection, industrial inspection, etc. The company has an advanced and efficient manufacturing platform with an annual production capacity of 50,000 units.

Eco Polymer specializes in designing and manufacturing plastic tubes and parts. They provide products for polyethylene, polypropylene, polyamine, elastomers, fluoropolymers, and other various polymers. They serve the medical instrument, auto, electronics, fiber optics, semiconductor, chemical engineering, environment, and analytics industries.

Human Zhizao is a technology platform that provides comprehensive diagnostic solutions. They provide clinical customers with a parallel, full-automatic multiple flow cytometry fluorescence detection platform and supporting reagents. They provide customer service. The flow fluorescence luminescence technology is a new generation of throughput detection and analysis platform integrating flow analysis, laser analysis, digital signal processing, and other technologies. They involve projects that require the joint detection of multiple indicators, such as autoantibodies, allergens, cytokines, etc.

Lealing Biotech developes anti-body based drugs and pharmaceutical products.

ProxyBio develops treatment and pharmaceutical products for mRNA development.

Hanchao Pharmaceutical is a biopharmaceutical company that specializes in the development and production of medical equipment and solutions for the biomedical industry. The company's core focus is on providing single-use bioprocessing solutions, with a particular emphasis on biomedical production technology. Hanchao independently designs, manufactures, and sells a range of equipment and consumables, catering to the industrialization stage of various biomedical fields, including antibodies, vaccines, antibody-drug conjugates (ADCs), and cell and gene therapies (CGTs).

Yangqi Intelligent provides answers for medical equipment. It provides goods like qise, elixir, wonder vision, odd control, and more. A self-made radiation body surface monitoring camera is called wonder vision. Qice is a platform for artificial intelligence-based medical models. Sales.

Pulnovo Medical, established in 2013 in Wuxi, Anhui, is focused on the development, production, and service provision of innovative medical technologies. The company specializes in creating advanced equipment for treating pulmonary hypertension, particularly through the use of pulse radiofrequency ablation technology. Its core products include pioneering high-frequency ablation equipment and intravascular catheters, which are protected by global invention patents. Pulnovo Medical aims to enhance the quality of life for patients suffering from pulmonary hypertension and heart failure by offering cutting-edge treatment solutions.

NeuShen Therapeutics is a biotechnology company focused on developing innovative therapies for neurological and psychiatric disorders. Utilizing a small molecule pipeline and an adeno-associated virus (AAV) gene therapy platform, the company aims to create effective medical solutions for mental illnesses. NeuShen Therapeutics is dedicated to advancing treatment options that offer patients both cures and relief from their symptoms, positioning itself at the forefront of therapeutic development in this critical area of healthcare.

Cell Probio is a manufacturer of cell culture consumables, positioned in the R&D, production and sales of high-end biological consumables.

Palline Data is a provider of hospital management solutions and operational data analysis. The company specializes in leveraging data to encourage hospital management to implement lean practices and refine medical resource allocation models through strategic adjustments. Palline employs statistical methods and artificial intelligence to develop mathematical models for performance evaluation and the creation of incentive systems. This enables hospital operators to perform strategy analysis and quantitative evaluations efficiently. Additionally, Palline offers a comprehensive suite of services, including management tools, big data applications, and software systems, aiming to enhance operational efficiency within healthcare institutions.

Zhongguancun Shuimu Medical Technology is the operator of a third-party, competent medical device compliance organization. Their business helps companies cut costs and time to market by offering medical device compliance services. It is dedicated to accelerating the registration and listing procedures for new medical device items as well as addressing the issue of how to industrialize creative medical device firms.

Joymed Technology specializes in the research and development, registration, and manufacturing of medical devices, providing comprehensive solutions tailored for medical equipment businesses. The company focuses on delivering innovative and reliable technology while ensuring high-quality standards in its products. By offering services such as device design, risk management, marketing, and product verification and validation, Joymed Technology enables its clients to develop and launch safe and affordable medical products efficiently. The company aims to become a trusted partner for both domestic and international medical device firms, particularly assisting small and medium-sized enterprises in navigating the complexities of the medical product market. Through flexible collaboration and optimized design processes, Joymed Technology seeks to accelerate mutual growth with its customers.

Future Vision is a visual health service organization based in Shanghai, specializing in the prevention and control of myopia, amblyopia rehabilitation training, and medical optometry for children aged 3 to 16. The company utilizes advanced North American optometry technology to deliver its services, aiming to address the growing concerns of visual health among children. By focusing on early intervention and comprehensive eye care, Future Vision seeks to improve the visual outcomes for its young clientele.

Ehomepoct is a healthcare management company based in Changsha, China, specializing in the manufacture of diagnostic test kits. The company produces a range of products, including pregnancy tests, inflammation tests, menstrual period tests, and early embryo testing kits. In addition to its diagnostic offerings, Ehomepoct integrates artificial intelligence into its healthcare solutions, enhancing rapid diagnosis and health management services. Through its innovative approach, Ehomepoct aims to improve medical treatment and facilitate better health outcomes.

Degron Therapeutics is a drug discovery company focused on developing a new class of therapeutics centered around targeted protein degradation. The company specializes in molecular glue degrader drugs, which are small molecules designed to selectively target and degrade specific proteins associated with various diseases. Degron Therapeutics aims to lead the field of small molecule molecular glue degrader medicines by leveraging its expertise to identify and validate challenging disease targets that traditional small molecule inhibitors cannot effectively address. The company is committed to addressing unmet medical needs across a broad range of therapeutic areas by developing innovative protein degradation drugs, utilizing its advanced molecular glue platform technology to enhance treatment efficacy.

SiranBio is a biotechnology company specializing in the development of innovative drugs based on small interfering RNA (siRNA) technology. The company focuses on creating single-target and dual-target nucleic acid drug platforms, as well as extrahepatic delivery systems. Its pipeline includes potential treatments for a wide range of diseases, such as viral infections, cardiovascular and metabolic disorders, autoimmune conditions, and central nervous system disorders. SiranBio aims to provide reliable and innovative products to its customers.

AccuPulse specializes in the development of advanced pulsed electric field ablation (PFA) systems designed for the treatment of atrial fibrillation (A-fib). The company focuses on creating innovative PFA generators and specialized catheters that serve as a comprehensive solution for the pulse ablation of A-fib and tumors. By integrating technologies that enhance catheter localization and signal acquisition, AccuPulse provides a more efficient and intelligent alternative to traditional interventional therapies, including radio frequency and cryotherapy. This approach aims to improve outcomes for both healthcare providers and patients by offering a more effective treatment option.

Resproly is a company dedicated to the research, development, production, and sales of formulations and equipment for respiratory inhalation. It operates as an integrated enterprise, concentrating on multiple clinically demanding treatment areas, including asthma, chronic obstructive pulmonary disease (COPD), diabetes, and Parkinson's disease. Resproly specializes in inhaled formulations and pulmonary drug delivery technology aimed at addressing the needs of patients suffering from these conditions.

NeuroEchos, established in 2017, specializes in functional neurosurgery with a focus on precise electroencephalogram (EEG) technology. The company offers integrated diagnostic and treatment solutions for diseases resulting from abnormal nervous system discharges. NeuroEchos utilizes artificial intelligence-assisted decision-making software to accurately interpret EEG waves, enhancing the diagnosis process. Additionally, they contribute to neuroscience research through their advanced deep brain electrodes.

Biocreatech is a biotechnology firm that uses protein design and synthetic biology to create cell factories capable of producing a range of products such as drug intermediates, fine chemicals, functional peptides, and therapeutic proteins. They involve in integrating multiple proteins into molecular machines in order to transform cells into factories.

Enzymaster (Ningbo) Bio-Engineering Co., Ltd. is a biotechnology company focused on the development and commercialization of innovative enzyme catalysis technologies. Founded in 2013 and based in Ningbo, China, the company specializes in the production of custom enzymes and biocatalytic synthesis for various applications, including active pharmaceutical ingredient intermediates, fine chemicals, and consumer goods. Enzymaster's product portfolio features compounds such as L-tert-leucine, Methyl (R)-3-Hydroxybutyrate, and D-Calcium Pantothenate. The company employs advanced techniques in enzyme-directed evolution, strain engineering, and fermentation process development to promote environmentally friendly and safe manufacturing practices across industries such as pharmaceuticals, food, and environmental conservation. Enzymaster is committed to sustainable practices and aims to contribute positively to society and the environment through its carbon-neutral intelligent manufacturing processes.

Farber Xintian CRO company engaged in clinical services of radionuclide drugs. The company focuses on the field of nuclide drugs. Through cooperation with domestic experts in the field of nuclide drugs, the company introduces IP and relies on its own resource advantages to create a VIC model for domestic nuclide drugs.

Junsai Shengwu developes therapies for new solid tumor cell.

Juncell Therapeutics is a biopharmaceutical company focused on developing innovative therapies for tumor treatment. The company specializes in tumor cell therapy, offering solutions to isolate tumor-infiltrating lymphocytes (TILs) from tumor tissues. These TILs are then cultivated outside the human body before being reintroduced to patients, aiming to enhance the body's ability to combat tumors while minimizing side effects. Through its research and development efforts, Juncell Therapeutics seeks to advance treatment options in the medical industry, ultimately improving patient outcomes in cancer therapy.

Shengshi Technology is a specialized platform focused on experimental simulation using computational fluid dynamics (CFD) and artificial intelligence for medical engineering research, particularly related to cardiovascular diseases. The company develops non-invasive precision diagnostic and treatment solutions, leveraging advanced technologies such as external fluid dynamics experimental simulation and CFD numerical simulation. By integrating these key technologies, Shengshi Technology aims to enhance the quality of healthcare services for both doctors and patients, ultimately improving outcomes in the management of cardiovascular conditions.

InnoBM Pharmaceuticals is a company specializing in the development of biomaterials and pharmaceutical products. It focuses on creating novel therapeutics aimed at enhancing the efficacy of tumor immunotherapy, thereby addressing critical needs in cancer treatment. By committing to innovation, InnoBM Pharmaceuticals strives to improve outcomes for cancer patients through advanced therapeutic solutions.

Guangwei Pharmaceuticals is a pharmaceutical manufacturer in China that produce medical theater products.

Yuanjingtaico is a biotech firm focused on the R&D of fluorescent PCR reagents, microfluidic, and electrochemical detection products.

KingstronBio specializes in the development and manufacturing of advanced heart valve products for cardiac surgeries. The company focuses on creating a comprehensive range of biological heart valves and annuloplasty rings that are designed to be minimally invasive. Utilizing cutting-edge technologies, including anti-calcification and leaflet thinning methods, KingstronBio aims to provide innovative solutions that enhance patient outcomes and improve the overall effectiveness of cardiac procedures.

Lingtai Biotechnology is a pharmaceutical and biotechnology based company that develops targeted protein degradation drugs.

Beijing Changmugu Medical Technology Co., Ltd. is a healthcare start-up that specializes in developing artificial intelligence-powered solutions for medical and surgical applications. Based in Beijing, China, the company focuses on enhancing orthopedic procedures through advanced technology. It offers a range of services including AI-assisted diagnosis, individualized surgical planning, 3D printing for patient-specific instrumentation, and post-operative evaluation. By leveraging deep learning algorithms, Changmugu Medical aims to improve the precision and safety of orthopedic surgeries, ultimately providing patients with more secure and reliable treatment options.

Comma Bio is a comprehensive solution provider for sample pretreatment. Based on two types of snap-neck material technologies of adsorption and separation materials and filter materials, the company has created three major technology platforms for porous plastics, separation materials and precision injection molding. Customers in the fields of, precision medicine, analysis and testing provide comprehensive solutions for sample pre-processing.

Tripod Preclinical Research is a Contract Research Organization that specializes in preclinical research services tailored for the biopharmaceutical industry. The company offers a comprehensive range of services, including nonhuman primate disease models, pharmacological efficacy assessments, early drug evaluations, and GLP toxicology. Tripod is committed to supporting global pharmaceutical companies, research and development enterprises, and medical device manufacturers in the evaluation of new chemical entities, food additives, biologics, pesticides, veterinary drugs, and cosmetics. Additionally, the organization provides technology support in areas such as translational medicine, clinical trials, biological analysis, and the management of biological sample banks, ensuring that its clients have the necessary resources to advance their research and development efforts effectively.

Hopstem Biotechnology LLC is a Houston-based company that focuses on the development of neural stem cell technology and stem cell therapies specifically for neurological disorders. Established in 2019, the company specializes in the neural differentiation, cell banking, and cell engineering of human induced pluripotent stem cells (iPSCs) and human embryonic stem cells (ESCs). By leveraging its advanced technologies, Hopstem aims to enhance biomedical research and improve diagnostic and therapeutic options for various neurological conditions. Through its innovative approaches, the company seeks to provide effective treatment solutions for patients suffering from these disorders.

Bioligo, officially known as Shanghai Bailige Biotechnology Co., Ltd., is a biotechnology company specializing in the provision of high-quality DNA synthesis and sequencing services. The company focuses on serving the genetic and molecular diagnostics sector, which is integral to the field of precision medicine. Bioligo offers a range of products, including DNA primers, fluorescently labeled probes, and RNA synthesis products. Additionally, they supply essential materials for next-generation sequencing library construction, such as adapters, blocking agents, and target capture probes. By addressing critical gaps in raw materials, Bioligo supports its downstream customers in the in vitro diagnostic industry, enhancing their capabilities in precision medicine applications.

Guangzhou Creative Biosciences, established in Guangzhou, China, specializes in the research, development, production, and sales of diagnostic kits for colorectal cancer screening. Their primary product is a non-invasive fecal DNA screening kit, which enables early detection of colorectal cancer by interpreting genetic abnormalities in feces. Additionally, the company offers diagnostic kits and equipment for lung cancer.

Boan Biotech is a fully integrated biopharmaceutical company dedicated to developing, manufacturing, and commercializing high-quality biologics. The company specializes in therapeutic antibodies, with a focus on key areas such as oncology, metabolism, autoimmunity, and ophthalmology. Boan Biotech operates primarily within Mainland China, generating revenue from customers in this region while also expanding its reach globally.

Vision X is a solutions provider for medical equipment in the field of ophthalmology and optometry.

Reforgene Medicine is a biomedical company focused on developing innovative drugs aimed at curing genetic diseases, chronic illnesses, and cancer. Utilizing advanced gene editing and genomic technologies, the company creates programmable medicine that offers targeted treatments for patients. By harnessing the potential of genome editing, Reforgene Medicine seeks to improve patient outcomes and contribute to the advancement of personalized healthcare solutions.

Alebund Pharmaceuticals is a biopharmaceutical company specializing in the discovery and development of innovative therapies for renal diseases and associated chronic conditions. The company focuses on researching and commercializing treatments for a variety of kidney-related ailments, including chronic kidney disease, dialysis complications, nephropathy, diabetic kidney disease, and autosomal dominant polycystic kidney disease. With a diversified pipeline of drug candidates, Alebund Pharmaceuticals aims to deliver comprehensive, high-quality solutions to patients suffering from renal diseases, addressing both immediate and long-term healthcare needs in this critical area.

NeuExcell Therapeutics is an early-stage gene therapy company dedicated to addressing neurodegenerative diseases and neural injuries. The company has developed an innovative neural repair technology that facilitates the conversion of astrocytes into neurons through in vivo methods. By employing adeno-associated virus-based gene therapy to introduce neural transcription factors, NeuExcell aims to enable clinicians to restore damaged neural tissue. The company's mission is to enhance the quality of life for millions of patients worldwide who are affected by neurodegenerative conditions.

Hopstem Biotechnology LLC is a Houston-based company that focuses on the development of neural stem cell technology and stem cell therapies specifically for neurological disorders. Established in 2019, the company specializes in the neural differentiation, cell banking, and cell engineering of human induced pluripotent stem cells (iPSCs) and human embryonic stem cells (ESCs). By leveraging its advanced technologies, Hopstem aims to enhance biomedical research and improve diagnostic and therapeutic options for various neurological conditions. Through its innovative approaches, the company seeks to provide effective treatment solutions for patients suffering from these disorders.

IntoCare is a high-tech company specializing in surgical products such as "Smart" powered staplers.

Suzhou Panomic Biomedical Technology Co., Ltd. (BioNovoGene) was founded in Suzhou Industrial Park Bio-Nano Park in 2013. It is a leading high-tech enterprise focusing on metabolomics in China. Since its establishment, it has established a complete metabolomics detection and analysis platform - PanomicTM / Bionovogene, including metabolite preprocessing platform, high-resolution mass spectrometry analysis platform, and metabolomics data analysis with independent intellectual property rights The system has perfect biomarker discovery capabilities and clinical application capabilities. The company's scientific research team has a rich background, covering biochemistry, bioinformatics, epidemiology and biostatistics, computer science, etc., and has a consultant team composed of top scientists and clinicians.

Next Generation Gene Therapeutics is a healthcare company that engages in the research and development of gene therapy. Its unique propriety technology of "one target and two bullets" can provide effective treatment for a variety of genetic diseases that currently have few therapeutic methods in the world. NGGT was founded in March 2020 by senior scientists and entrepreneurs in the field of gene therapy. It is committed to becoming the world's leading gene therapy company with international influence. The company has successful experience in the whole industry chain, concerning the early development of gene therapy products, the large-scale production of viral vectors, the construction of quality standards, international multi-center clinical research, and the application for the marketing of gene therapy products.

Brattea is a medical device research and development company specializing in renal denervation products aimed at addressing various health conditions, including hypertension, cancer pain, and diabetes. The company develops interventional devices that include renal artery ablation catheters, radiofrequency ablation equipment, and medical mapping systems. These products are designed to treat a range of medical issues, such as refractory hypertension, obstructive sleep apnea, kidney disease, and heart failure. Through its innovative approach, Brattea aims to provide reliable solutions that improve patient outcomes and enhance the quality of care in the medical field.

Synaptic Medical Inc. is a medical device company dedicated to developing and commercializing innovative products aimed at treating cardiac arrhythmias and other cardiovascular diseases. Established in 2005 and headquartered in St. Paul, Minnesota, the company also maintains an office in Beijing, China. Synaptic Medical specializes in cardiac electrophysiology, offering a range of products including bipolar pacing systems, fixed curve and deflectable diagnostic catheters, pulmonary vein mapping catheters, and ablation devices. The company's focus is on creating unique, cost-effective, and clinically advanced technologies that enhance treatment options for physicians and their patients.

Tavotek Biotherapeutics is a biopharmaceutical company dedicated to discovering, developing, and commercializing therapeutic medicines for patients with severe, underserved diseases. Led by experienced pharmaceutical executives, the company employs three distinct research and development platforms: TavoSelect, an innovative phage display library; TavoPrecise, a platform for engineering tissue-specific biologics; and TavoMIP, a multicyclic peptide platform. Tavotek's pipeline includes various product candidates targeting cancers, autoimmune conditions, and infectious diseases.

Pro-Heal Pharmaceuticals is a biotechnology company that specializes in the development and manufacturing of pharmaceutical products. It focuses on creating drugs for ophthalmic and autoimmune diseases, addressing critical needs in the pharmaceutical field. By concentrating on biological macromolecule therapies and ophthalmology medicines, Pro-Heal aims to provide effective treatments that are currently lacking in clinical settings, thereby improving patient outcomes. The company's commitment to innovation and development positions it as a valuable player in the healthcare industry, dedicated to meeting urgent medical needs.

Beijing Changmugu Medical Technology Co., Ltd. is a healthcare start-up that specializes in developing artificial intelligence-powered solutions for medical and surgical applications. Based in Beijing, China, the company focuses on enhancing orthopedic procedures through advanced technology. It offers a range of services including AI-assisted diagnosis, individualized surgical planning, 3D printing for patient-specific instrumentation, and post-operative evaluation. By leveraging deep learning algorithms, Changmugu Medical aims to improve the precision and safety of orthopedic surgeries, ultimately providing patients with more secure and reliable treatment options.

KYinno is a drug development company that is dedicated to oncology drug development with a focus on immune treatments against cancer.

Huikai Medical is a specialized manufacturer and developer of minimally invasive urological medical devices. Its product portfolio focuses on addressing key urinary system conditions such as prostatic hyperplasia, urinary stones, incontinence, and urological tumors. The company's innovative devices are designed to enhance patient comfort and efficiency in medical settings, utilizing proprietary technology and materials for superior clinical outcomes.

VesiCURE Therapeutics is a biotechnology company based in Suzhou, Jiangsu, China, founded in 2021. It specializes in the research and development of innovative drugs utilizing exosomes, also known as extracellular vesicles. The company is dedicated to advancing the understanding and application of exosomal drugs, contributing to the growth and enhancement of the exosomal pharmaceutical industry. Through its research initiatives, VesiCURE aims to promote the development of effective therapies that harness the unique properties of exosomes for medical applications.

PegBio Co., Ltd., established in 2008 and headquartered in Suzhou, China, is a biopharmaceutical company specializing in the development and manufacturing of polyethylene glycol (PEG) and PEGylation technology. The company offers a range of PEG synthesis technologies, including N-terminal specific, thiol-selective, and enzymatic PEGylation, as well as pharmaceutical-grade PEGs for biopharmaceutical applications. PegBio also provides reagent-grade mPEGs with varying molecular weights, structures, and activation groups, catering to both domestic and international customers in academia and the pharmaceutical industry. Additionally, the company offers PEGylation services for chemical modifications of macromolecules and develops PEGylated products, such as PB-119, an agonist of glucagon-like peptide 1 (GLP-1) for treating type 2 diabetes. PegBio's PEGylation technology is employed to modify proteins, peptides, antibody fragments, oligonucleotides, and small molecules, serving universities, research institutes, and pharmaceutical companies.

Shanghai OMNI Pharmaceutical Technology Co., Ltd. is a pharmaceutical company based in Shanghai, China, specializing in the research, development, and manufacturing of respiratory products. Founded in 2006, OMNI focuses on both generic and branded pharmaceuticals aimed at treating chronic diseases such as Chronic Obstructive Pulmonary Disease (COPD) and asthma. The company offers a range of dosage forms, including inhalation dry powders, nasal sprays, HFA aerosols, and sustained-release capsules and tablets. OMNI also provides contract manufacturing and clinical research services for complex drug delivery systems that are challenging to develop and manufacture. By leveraging its expertise, the company aims to address public health challenges in regulated markets, including North America, Europe, and China.

Yingsheng Biotechnology Co., Ltd., established in 2009, specializes in the development of in vitro diagnostic reagents and medical equipment focused on maternal and child health, neonatal genetic diseases, metabolic disorders, and birth defects. The company offers a diverse product line that includes 45 innovative screening reagents for genetic metabolic diseases, deaf genetic testing kits, vitamins determination reagents, and an HLA-B27 detection kit. Yingsheng also provides advanced diagnostic technologies such as a mass spectrometer automatic intelligent processing platform and ultra-high performance liquid chromatography tandem mass spectrometry detection systems. Through its innovative products, Yingsheng aims to facilitate early detection of genetic conditions, promoting timely intervention and better health outcomes for patients.

GensKey is a medical diagnostic service provider specializing in genetic testing for pathogen diagnosis. The company utilizes high-throughput sequencing technology combined with intelligent algorithm analysis to address challenges associated with traditional diagnostic methods, such as low detection rates, lengthy processes, and accuracy issues. By improving the timeliness and precision of pathogen diagnosis, GensKey enables patients suffering from severe infections to receive prompt and reliable diagnoses, thereby enhancing the potential for effective treatment and recovery.

Zylox Medical Device Co., founded in 2012 in Hangzhou, is a specialized company focused on developing innovative medical devices for interventional procedures. Established by a team of experienced professionals with backgrounds in top-tier medical device manufacturers, Zylox offers a diverse range of products primarily aimed at peripheral vascular and neurovascular interventions. Its product line includes various devices such as PTA balloons, drug-coated PTA balloons, superficial femoral artery (SFA) stents, and the Thrombite Clot Retriever Device. Zylox is committed to improving patient outcomes by consistently enhancing its cutting-edge medical technologies and ensuring the highest quality standards.

Beijing Delta Medical Co., Ltd. specializes in the design and manufacture of orthopedic surgical instruments and rehabilitation products. The company offers a range of products, including shoulder arthroscopic instruments, various types of suture anchors, instruments for anterior and posterior cruciate ligament reconstruction, interference screws, and shaver systems. In addition to its surgical instruments, Delta Medical provides sports rehabilitation services. The company is headquartered in Beijing, China, and focuses on delivering innovative solutions in sports medicine.

Zhejiang Pushikang Biotechnology offer In-vitro diagnostics solutions.

X-ABT is a tech enterprise that provides solutions for pathogenic microorganism detection in the medical and health fields. The company focuses on providing complete solutions for the detection of infectious pathogens in the medical and health field. They develop and produce systems for disease control, prevention, clinical hospitals, and entry-exit customs. X-ABT also provides clinical marketing and sales services to help medical workers and serve patients.

Borayer is a biotechnology company that specializes in the development and production of biological materials for clinical medicine. The company focuses on creating medical consumables aimed at wound repair, including products that facilitate rapid hemostasis, wound adhesion, and guided tissue regeneration. Through its innovative offerings, Borayer aims to enhance clinical medical products and technologies, contributing to improved patient outcomes in various healthcare settings.

IntoCare is a high-tech company specializing in surgical products such as "Smart" powered staplers.

AIVFO produces full-line culture fluids and intelligent automation equipment.

Shanghai Bioheart Biotechnology Co., Ltd., established in 2014 and located in Shanghai, China, specializes in the development of drug-eluting stents. The company is focused on creating innovative, high-value minimally invasive therapeutic products. Bioheart aims to enhance medical technology and provide superior healthcare solutions for medical professionals and patients alike, positioning itself as a significant player in the medical and healthcare industry.

Shenzhen Dami He Xiaomi Cultural Broadcast Co., Ltd., known as Dami & Xiaomi, operates an online platform dedicated to supporting children with autism spectrum disorders. Established in 2014 and based in Shenzhen, China, the company offers a range of integrated services including rehabilitation, educational support, parent training, online courses, and science information. Dami & Xiaomi aims to address the needs of children with developmental disorders, focusing on effective strategies to help them manage autism and promote healthy growth. Through its comprehensive platform, it provides essential resources to empower parents and caregivers in their efforts to support their children's development.

EOC Pharma Group is a biopharmaceutical company based in Shanghai, China, founded in 2015. It specializes in the development, manufacturing, and commercialization of innovative oncology products. EOC employs a licensing model to enhance its product pipeline by incorporating molecules from global biopharmaceutical partners into its robust local infrastructure, which includes manufacturing, clinical development, regulatory filing, and commercialization. The company has a diverse pipeline featuring seven novel products, several of which are positioned as potentially first- and best-in-class. EOC has achieved regulatory milestones with four Class I innovative drug approvals and has initiated clinical studies for its leading products. The company operates an 8,000 square meter cGMP manufacturing facility in Taizhou and maintains offices in key locations, including Shanghai, Beijing, Hong Kong, and Los Angeles. With a team of experienced professionals, EOC aims to establish itself as a leader in oncology innovation in China through strategic partnerships and a comprehensive integrated platform.

Ruixun Biotech is a healthcare company that provides biotechnology. Ruixun Biotech combines microfluidics, optics, precision instruments, electronic engineering, and biochemical technologies to create upstream equipment and consumables for molecular diagnosis and genetic testing. They released a number of products, including the digital PCR apparatus DropX-2000 and more than 50 different RUO detection kits.